Cite
Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus
MLA
Tetsuo Shoji, et al. “Effects of Pioglitazone on Serum Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus.” Metabolism: Clinical and Experimental, vol. 57, no. 9, Oct. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec69cc59d2a93addba9b8a4127d6e402&authtype=sso&custid=ns315887.
APA
Tetsuo Shoji, Masaaki Inaba, Takahiro Araki, Eiko Lee, Katsuhito Mori, Megumi Teramura, Yoshiki Nishizawa, Hisayo Yokoyama, Hidenori Koyama, & Masanori Emoto. (2007). Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism: Clinical and Experimental, 57(9).
Chicago
Tetsuo Shoji, Masaaki Inaba, Takahiro Araki, Eiko Lee, Katsuhito Mori, Megumi Teramura, Yoshiki Nishizawa, Hisayo Yokoyama, Hidenori Koyama, and Masanori Emoto. 2007. “Effects of Pioglitazone on Serum Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus.” Metabolism: Clinical and Experimental 57 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec69cc59d2a93addba9b8a4127d6e402&authtype=sso&custid=ns315887.